MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-13-0004378
The Trinity Pharmaceuticals (India) Pvt Ltd - pharma in Aranattukara, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.54 Cr
▲ 3% YoY
Net profit · FY 2025
₹15,823
Net margin 0.1%
EBITDA · FY 2025
₹13.27 Lakh
EBITDA margin 5.2%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹79.22 Lakh
Issued & subscribed
Open charges
₹80.47 Lakh
Satisfied ₹98.9 Lakh
Company age
81 yrs
Est. 1945
Directors on board
3
As per MCA filings
About The Trinity Pharmaceuticals (India) Pvt Ltd
Data last updated:
The Trinity Pharmaceuticals (India) Pvt Ltd is a private limited company based in Aranattukara, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 1945 and has been in existence for over 81 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1945PTC001682. Its GSTIN is 32AAACT8729L2Z0 (Kerala). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹79.22 Lakh. It was formerly known as The Trinity Pharmaceuticals (India) Ltd. It is led by directors including Ranjith Damodaran (Managing Director) and Ajay Jagan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No: 17/317 Raj Vihar Annexe Poothole P.O., Aranattukara, Kerala, India – 680004.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.54 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹15,823 (net margin 0.1%) and EBITDA of ₹13.27 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹80.47 Lakh and satisfied charges of ₹98.9 Lakh on record. Court records list 13 cases involving the company, including 8 filed by the company and 5 filed against it; 4 cases are pending.
The Trinity Pharmaceuticals (India) Pvt Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-13-0004378). The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website trinitypharma.in.
Company details
CIN U24231KL1945PTC001682
Registration Number 001682
Incorporation Date 12 November 1945
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-13-0004378
Recognitions & Rankings of The Trinity Pharmaceuticals (India)
Contact details
The Trinity Pharmaceuticals (India) Pvt Ltd's registered office is in Aranattukara, Kerala. Its website is trinitypharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressDoor No: 17/317 Raj Vihar Annexe Poothole P.O., Aranattukara, Kerala, India – 680004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Comprehensive company report
The Trinity Pharmaceuticals (India) Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of The Trinity Pharmaceuticals (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Financials of The Trinity Pharmaceuticals (India) Pvt Ltd
FY 2025 filings availableThe Trinity Pharmaceuticals (India) Pvt Ltd reported revenue of ₹2.54 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹2.54 Cr ▲ 3%
Net profit · FY 2025
₹15,823 margin 0.1%
EBITDA · FY 2025
₹13.27 Lakh margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 2%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 2%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 3% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,823 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Board of directors of The Trinity Pharmaceuticals (India) Pvt Ltd
The Trinity Pharmaceuticals (India) has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Jagan | Director | 10 Jun 1996 | 30 Years 4 Months | Current |
| Anand Aravind | Director | 10 Jun 1996 | 30 Years 4 Months | Current |
| Ranjith Damodaran | Managing Director | 11 Jul 2009 | 17 Years 3 Months | Current |
Peer comparison
The Trinity Pharmaceuticals (India) Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| The Trinity Pharmaceuticals (India) Pvt Ltdthis company | ₹2.54 Cr (FY 2025) | ₹15,823 | 0.1% | 3.0% | Aranattukara, Kerala, India | |
| Nexus Drugs Private Limited | ₹2.54 Cr (FY 2024) | -60.0% | Hyderabad, Telangana, India | |||
| Timon Pharmaceuticals Private Limited | ₹2.54 Cr (FY 2019) | 13.0% | Chennai, Tamil Nadu, India | |||
| Medchl Chemicals and Pharmaceuticals Pvt.Ltd. | ₹2.53 Cr (FY 2016) | -37.0% | Secunderabad, Telangana, India |
To see the full peer comparison of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Auditor
The Trinity Pharmaceuticals (India) Pvt Ltd is audited by Manesh Rineesh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Manesh Rineesh & Associates | FY 2023 | 013634S |
Shareholding
The shareholding of The Trinity Pharmaceuticals (India) Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹80.47 Lakh
Satisfied charges
₹98.9 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2019 | 100315381 | Others | ₹80.47 Lakh | Open | |
| 05 Aug 2008 | 10118149 | State Bank of Travancore | ₹45 Lakh | Satisfied | |
| 07 Feb 2004 | 90019619 | The Dharmodayam Company | ₹40,000 | Satisfied | |
| 07 Jan 2004 | 90019564 | State Bank of Travancore | ₹12 Lakh | Satisfied | |
| 31 Jan 2003 | 90019005 | State Bank of Travancore | ₹26 Lakh | Satisfied |
To see the full charge records of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Total charge records: 7 View all charges
Legal cases
The Trinity Pharmaceuticals (India) Pvt Ltd has 13 court cases on record: 8 filed by The Trinity Pharmaceuticals (India), 5 filed against it. 4 cases are pending and 9 are disposed.
Total cases
13
Filed by the company
8
Filed against the company
5
Pending
4
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 2 | 2 |
| District courts | 4 | 3 | 2 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against Thrissur Corporation and 4 others | Pending |
| District court, Thrissur, Kerala | Civil suit | Filed against the company by Trinity Pharma Care | Pending |
| High Court | Writ petition | Filed by the company against The State of Kerala and 4 others | Pending |
| District court, Thrissur, Kerala | Civil suit | Filed by the company against individuals | Pending |
| High Court | Writ petition | Filed against the company by an individual | Disposed |
To see the full case history of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for The Trinity Pharmaceuticals (India) Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
The Trinity Pharmaceuticals (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACT8729L2Z0 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of The Trinity Pharmaceuticals (India) Pvt Ltd, buy the company report.
Recent activity
The Trinity Pharmaceuticals (India) Pvt Ltd has 11 board changes on record since 1996: 3 appointments and 8 cessations. The latest: Balakrishna Kurup Sreevalsan ceased to be Director on 30 Dec 2017.
AGM
The Trinity Pharmaceuticals (India) Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
The Trinity Pharmaceuticals (India) Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 07 Jan 2004 via Charge ID 90019564 with State Bank Of Travancore was fully satisfied on 27 Jun 2024.
Charges
A charge registered on 31 Jan 2003 via Charge ID 90019005 with State Bank Of Travancore was fully satisfied on 27 Jun 2024.
Charges
A charge registered on 26 Mar 1987 via Charge ID 90015607 with State Bank Of Travancore was fully satisfied on 27 Jun 2024.
Charges
A charge registered on 07 Feb 2004 via Charge ID 90019619 with The Dharmodayam Company was fully satisfied on 26 Jun 2024.
Charges
A charge with Others of Rs. 80.47 Lakh registered on 21 Nov 2019 with Charge ID 100315381 was modified on 30 Jun 2020.
Charges
A charge registered on 05 Aug 2008 via Charge ID 10118149 with State Bank Of Travancore was fully satisfied on 30 Nov 2019.
Charges
A charge with Others amounted to Rs. 80.47 Lakh with Charge ID 100315381 was registered on 21 Nov 2019.
Ceased
Balakrishna Kurup Sreevalsan ceased to be Director.
Ceased
Prasad Aravind ceased to be Director.
Ceased
Preethi Sreevalasan ceased to be Director.
18 earlier events are in the company report.
Frequently asked questions
The Trinity Pharmaceuticals (India) is an active private limited company based in Aranattukara, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 November 1945 (81+ years old) and is registered under CIN U24231KL1945PTC001682.
The Trinity Pharmaceuticals (India) has 3 current directors:
- Ranjith Damodaran - Managing Director
- Ajay Jagan - Director
- Anand Aravind - Director
The latest financial statements of The Trinity Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of The Trinity Pharmaceuticals (India) is 32AAACT8729L2Z0, registered in Kerala. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of The Trinity Pharmaceuticals (India) is U24231KL1945PTC001682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The Trinity Pharmaceuticals (India) has 13 court cases on record: 8 filed by the company and 5 filed against it. 4 are pending. Most are in the high courts.
The Trinity Pharmaceuticals (India) was incorporated on 12 November 1945, making it 81+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of The Trinity Pharmaceuticals (India) by revenue are Nexus Drugs Private Limited, Timon Pharmaceuticals Private Limited, Medchl Chemicals and Pharmaceuticals Pvt.Ltd, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Balakrishna Kurup Sreevalsan ceased to be Director on 30 Dec 2017. Prasad Aravind ceased to be Director on 30 Dec 2017. Preethi Sreevalasan ceased to be Director on 30 Dec 2017. The Trinity Pharmaceuticals (India) has 11 board changes on record in total.
Yes, The Trinity Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-13-0004378).
The Trinity Pharmaceuticals (India) can be reached through the website trinitypharma.in. Its registered office is in Aranattukara, Kerala, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages